Abacavir
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2543 publications
Longitudinal Clinical and Molecular Characterization of a Single Pediatric Case of Vertically Acquired HIV-1 Subtype C with Baseline Resistance to Protease Inhibitors.
Journal: Microorganisms
Published: June 10, 2026
Early outcomes of South African children with persistent viral non-suppression following switch to dolutegravir-based antiretroviral therapy.
Journal: Southern African journal of HIV medicine
Published: May 25, 2026
Drug-associated psoriasis: a pharmacovigilance study based on the FAERS database.
Journal: Frontiers in pharmacology
Published: May 22, 2026
Potential Pharmacogenomics (PGx), Human Leukocyte Antigen (HLA) Antiviral to Cephalosporin Crossover Reaction.
Journal: Journal of pharmacy practice
Published: May 06, 2026
It's about time: The association between abacavir and cardiovascular disease.
Journal: Antiviral therapy
Published: April 24, 2026
HIV viral suppression outcomes of Tenofovir- and Abacavir-based antiretroviral regimens among children on ART in Zambia.
Journal: Frontiers in public health
Published: April 20, 2026
Forced degradation study of abacavir using the electrochemistry-mass spectrometry setup.
Journal: Journal of pharmaceutical and biomedical analysis
Published: April 05, 2026
CYP1A2 and ADH1C contribute to abacavir aldehyde intermediate formation in the human liver.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: March 23, 2026
Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial.
Journal: The Pediatric infectious disease journal
Published: February 24, 2026
Last Updated: 09/26/2026